- Previous Close
3,000.00 - Open
3,000.00 - Bid 2,950.00 x --
- Ask 3,025.00 x --
- Day's Range
2,950.00 - 3,045.00 - 52 Week Range
2,750.00 - 5,800.00 - Volume
3,954 - Avg. Volume
5,949 - Market Cap (intraday)
24.744B - Beta (5Y Monthly) 1.01
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea.
www.bifido.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 238200.KQ
View MorePerformance Overview: 238200.KQ
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 238200.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 238200.KQ
View MoreValuation Measures
Market Cap
24.54B
Enterprise Value
33.74B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.99
Price/Book (mrq)
0.53
Enterprise Value/Revenue
2.73
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.31%
Return on Assets (ttm)
-0.78%
Return on Equity (ttm)
0.47%
Revenue (ttm)
18.48B
Net Income Avi to Common (ttm)
242.14M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
14.07B
Total Debt/Equity (mrq)
23.43%
Levered Free Cash Flow (ttm)
-15.34B